Ashlee Crumpton, 27, spoke to Newsweek about her hellish journey, which has been praised by New York-based dermatologist Dr. Hannah Kopelman.
Journey Medical's new rosacea treatment will rival industry giant Galderma's Oracea in the treatment of rosacea.
Fortress Biotech, Inc. (NASDAQ: FBIO) announced through its majority-controlled subsidiary, Journey Medical Corporation, that the U.S. Food and Drug Administration (FDA) has approved Emrosi™ ...